Opening Bell Analyst Calls Briefing for Tuesday, November 1, 2022
Here is a final look at analysts' calls from just before Tuesday's opening bell.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Downgrades:
> DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $72
> Inovio Pharma (INO) downgraded to Underperform from Neutral at BofA Securities; tgt $2
> Instil Bio (TIL) downgraded to Hold from Buy at Truist; tgt lowered to $6
> Skechers USA (SKX) downgraded to Hold from Buy at Argus
> Varonis Systems (VRNS) downgraded to Hold from Buy at Craig Hallum
> Ventas (VTR) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $46
> Welltower (WELL) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $70
Others:
> Cairn Energy (CRNCY) resumed with an Equal Weight at Barclays
Research calls posted earlier this morning are available here and here.
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
